Mission – “Contribute to Society by Developing Critical but Neglected Pharmaceuticals and Medical Devices.”
We are committed to developing treatments and medical devices for diseases that often go overlooked because of the small number of patients.
We believe that we have a societal obligation to develop therapies and medical devices that help improve the lives of people living with diseases that have limited or no other treatment options.
We gauge success by the people we help and the advances we bring to patient care.
Jin Shiomura, Managing Director and CEO of Nobelpharma Co. Ltd., has published an article in which he talks about Nobelpharma.*
Interested to learn more about Nobelpharma Co. Ltd., download the article by clicking onto the article.
*Nobelpharma products are approved in Japan only and the drugs have not been approved or deemed safe and effective by the U.S. FDA.
This website contains information about products that may not be available in the U.S. Nothing contained herein should be considered a solicitation, promotion or advertisement for any product including those under development.